According to our knowledge, the present study is the first to indicate the diagnostic usefulness of CXCL-8 levels in the sera of patients with OC in comparison with the classical tumor markers (CEA and SCC-Ag) and the well-established marker of inflammation—C-reactive protein (CRP). Here, CEACAM5 is linked to neoplasm.